Silver nanoparticle applications and human health.

King Abdullah Institute for Nanotechnology, King Saud University, Riyadh-11451, Saudi Arabia.
Clinica chimica acta; international journal of clinical chemistry (Impact Factor: 2.54). 12/2010; 411(23-24):1841-8. DOI: 10.1016/j.cca.2010.08.016
Source: PubMed

ABSTRACT Nanotechnology is rapidly growing with nanoparticles produced and utilized in a wide range of commercial products throughout the world. For example, silver nanoparticles (Ag NP) are used in electronics, bio-sensing, clothing, food industry, paints, sunscreens, cosmetics and medical devices. These broad applications, however, increase human exposure and thus the potential risk related to their short- and long-term toxicity. A large number of in vitro studies indicate that Ag NPs are toxic to the mammalian cells derived from skin, liver, lung, brain, vascular system and reproductive organs. Interestingly, some studies have shown that this particle has the potential to induce genes associated with cell cycle progression, DNA damage and apoptosis in human cells at non-cytotoxic doses. Furthermore, in vivo bio-distribution and toxicity studies in rats and mice have demonstrated that Ag NP administered by inhalation, ingestion or intra-peritoneal injection were subsequently detected in blood and caused toxicity in several organs including brain. Moreover, Ag NP exerted developmental and structural malformations in non-mammalian model organisms typically used to elucidate human disease and developmental abnormalities. The mechanisms for Ag NP induced toxicity include the effects of this particle on cell membranes, mitochondria and genetic material. This paper summarizes and critically assesses the current studies focusing on adverse effects of Ag NPs on human health.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Over the years there has been a significant increase in the manufacturing of silver nanoparticles-based products, mainly due to their antimicrobial activity, with application in medicine and textile and food industry. However, the inappropriate use and disposal of these materials can allow the entry of silver nanoparticles (AgNP) compounds into the aquatic environment, with potential toxicological effects. In this study we have used Pseudokirchneriella subcapitata, Artemia salina and Daphnia similis as model organisms to investigate the toxicity of PVA-stabilized AgNP at several concentration levels. AgNP were physico-chemically characterized by UV-Vis spectroscopy, particle size distribution, zeta potential analyzes and Transmission Electron Microscopy (TEM). AgNP presented a maximum absorption at 400 nm and size range between 2 and 18 nm. Each specific organism was exposed to AgNP concentrations through standardized protocol. For P. subcapitata and Artemia salina the EC50 value found, 1.09 mgL-1 and 5.5×10-2 mg⧸L, respectively, were in accordance to previous results reported in the literature. However, for D. similis, the EC50 24-48 h values indicate a higher toxicity than other results reported for other daphnids.
    Environmental Nanotechnology, Monitoring & Management. 11/2014;
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Nanomaterials with near-infrared (NIR) absorption have been widely studied in cancer detection and photothermal therapy (PTT), while it remains a great challenge in targeting tumor efficiently with minimal side effects. Herein we report a novel multifunctional phage-mimetic nanostructure, which was prepared by layer-by-layer self-assembly of Au@Ag heterogenous nanorods (NRs) with rhodamine 6G, and specific pVIII fusion proteins. Au@Ag NRs, first being applied for PTT, exhibited excellent stability, cost-effectivity, biocompatibility and tunable NIR absorption. The fusion proteins were isolated from phage DDAGNRQP specifically selected from f8/8 landscape phage library against colorectal cancer cells in a high-throughput way. Considering the definite charge distribution and low molecular weight, phage fusion proteins were assembled on the negatively charged NR core by electrostatic interactions, exposing the N-terminus fused with DDAGNRQP peptide on the surface. The fluorescent images showed that assembled phage fusion proteins can direct the nanostructure into cancer cells. The nanostructure was more efficient than gold nanorods and silver nanotriangle-based photothermal agents and was capable of specifically ablating SW620 cells after 10 min illumination with an 808 nm laser in the light intensity of 4 W/cm(2). The prepared nanostructure would become an ideal reagent for simutaneously targeted optical imaging and PTT of tumor.
    Scientific Reports 10/2014; 4:6808. · 5.08 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The current rapid development of nanotechnologies and engineered nanomaterials (ENM) will impact the society in a major fashion during the coming decades. This development also causes substantial safety concerns. Among the many promising applications of ENM, products that can be used for diagnosis and treatment of diseases, including conditions that affect the nervous system, are under development. ENM can pass the blood brain barrier (BBB) and accumulate within the brain. It seems that the nano-form rather than the bulk form of the chemicals pass the BBB, and that there is an inverse relationship between particle size and the ability to penetrate the BBB. Although translocation of ENM to the brain is possible during experimental conditions, the health relevance for real-life situations is far from clear. One major reason for this is that studies have been using nanoparticle concentrations that are far higher than the ones that can be expected during realistic exposures. However, very high exposure to the CNS can cause effects on neurotransmission, redox homeostasis and behavior. Available studies have been focusing on possible effects of the first generation of ENM. It will be necessary to study possible health effects also of expected novel sophisticated materials, independent of the outcome of present studies. The prospects for intended or targeted medical applications are promising since it has been shown that ENM can be made to pass the BBB and reach specific regions or cells within the brain.
    Current Medicinal Chemistry 12/2014; 21(37). · 3.72 Impact Factor


Available from
May 23, 2014